News
Public · Published
Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
Capricor Therapeutics will release its third quarter 2026 financial results after the market close on Tuesday, November 10, 2026. Management will host a conference call and webcast at 4:30 p.m. ET that same day, with a replay available afterward.
Published:
Updated:
What happened
Capricor Therapeutics will release its third quarter 2026 financial results after the market close on Tuesday, November 10, 2026. Management will host a conference call and webcast at 4:30 p.m. ET that same day, with a replay available afterward.
Confirmed
Global impact / market context
Quarterly results show how much cash the company has and how quickly it is spending it. For a biotechnology company funding late-stage drug development, that spending pace affects how long it can operate before raising more money.
Analyst inference
Investors in small biotechnology companies often focus on cash and spending trends rather than revenue, since revenue can be limited before products are approved. The update may also cover progress on Deramiocel, its cell therapy for Duchenne muscular dystrophy.
Analyst inference
What to watch
- The earnings release is scheduled for after the market close on November 10, 2026, and the call begins at 4:30 p.m. ET that day. Confirmed
- Watch whether the company describes its cash balance and spending pace in a way that suggests enough funding for planned development work, or points to future fundraising. Analyst inference
- Watch for any update on Deramiocel, including regulatory steps or trial progress, since that program is central to the company's long-term prospects. Analyst inference